WINSOME DIAMONDS | REMUS PHARMA | WINSOME DIAMONDS/ REMUS PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -0.0 | - | - | View Chart |
P/BV | x | - | 60.3 | - | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
WINSOME DIAMONDS REMUS PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
WINSOME DIAMONDS Mar-17 |
REMUS PHARMA Mar-23 |
WINSOME DIAMONDS/ REMUS PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 1 | NA | - | |
Low | Rs | NA | NA | - | |
Sales per share (Unadj.) | Rs | 0 | 413.1 | 0.0% | |
Earnings per share (Unadj.) | Rs | -78.4 | 78.0 | -100.5% | |
Cash flow per share (Unadj.) | Rs | -78.0 | 82.4 | -94.7% | |
Dividends per share (Unadj.) | Rs | 0 | 2.00 | 0.0% | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | -53.1 | 175.6 | -30.3% | |
Shares outstanding (eoy) | m | 106.61 | 1.09 | 9,780.7% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0 | 0 | - | |
Avg P/E ratio | x | 0 | 0 | - | |
P/CF ratio (eoy) | x | 0 | 0 | - | |
Price / Book Value ratio | x | 0 | 0 | - | |
Dividend payout | % | 0 | 2.6 | -0.0% | |
Avg Mkt Cap | Rs m | 58 | 0 | - | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 3 | 55 | 4.9% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 0 | 450 | 0.0% | |
Other income | Rs m | 639 | 16 | 4,054.6% | |
Total revenues | Rs m | 639 | 466 | 137.2% | |
Gross profit | Rs m | -1,775 | 105 | -1,682.7% | |
Depreciation | Rs m | 44 | 5 | 913.6% | |
Interest | Rs m | 7,177 | 2 | 308,040.8% | |
Profit before tax | Rs m | -8,356 | 114 | -7,320.9% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 4 | 29 | 14.0% | |
Profit after tax | Rs m | -8,360 | 85 | -9,832.0% | |
Gross profit margin | % | 0 | 23.4 | - | |
Effective tax rate | % | 0 | 25.5 | -0.2% | |
Net profit margin | % | 0 | 18.9 | - |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 507 | 113 | 446.7% | |
Current liabilities | Rs m | 63,052 | 82 | 77,251.1% | |
Net working cap to sales | % | 0 | 7.1 | - | |
Current ratio | x | 0 | 1.4 | 0.6% | |
Inventory Days | Days | 0 | 167 | - | |
Debtors Days | Days | 0 | 393 | - | |
Net fixed assets | Rs m | 56,934 | 232 | 24,551.2% | |
Share capital | Rs m | 1,065 | 11 | 9,813.0% | |
"Free" reserves | Rs m | -6,728 | 181 | -3,727.4% | |
Net worth | Rs m | -5,664 | 191 | -2,959.7% | |
Long term debt | Rs m | 0 | 71 | 0.0% | |
Total assets | Rs m | 57,441 | 345 | 16,633.2% | |
Interest coverage | x | -0.2 | 50.0 | -0.3% | |
Debt to equity ratio | x | 0 | 0.4 | -0.0% | |
Sales to assets ratio | x | 0 | 1.3 | 0.0% | |
Return on assets | % | -2.1 | 25.3 | -8.1% | |
Return on equity | % | 147.6 | 44.4 | 332.2% | |
Return on capital | % | 20.8 | 44.4 | 46.9% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 1.1 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | 5 | 0.0% | |
Fx inflow | Rs m | 0 | 440 | 0.0% | |
Fx outflow | Rs m | 0 | 18 | 0.0% | |
Net fx | Rs m | 0 | 422 | 0.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 7,171 | 53 | 13,496.7% | |
From Investments | Rs m | 1 | -152 | -0.8% | |
From Financial Activity | Rs m | -7,177 | 118 | -6,098.5% | |
Net Cashflow | Rs m | -5 | 19 | -28.2% |
Indian Promoters | % | 25.2 | 70.6 | 35.7% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 2.4 | 3.9 | 60.2% | |
FIIs | % | 2.3 | 3.3 | 70.8% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 74.8 | 29.4 | 254.4% | |
Shareholders | 47,477 | 1,124 | 4,223.9% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare WINSOME DIAMONDS With: ADANI ENTERPRISES REDINGTON MMTC SIRCA PAINTS INDIA
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | SU-RAJ DIAMONDS | REMUS PHARMA |
---|---|---|
1-Day | 0.00% | 0.06% |
1-Month | -2.78% | 34.07% |
1-Year | -30.00% | 144.57% |
3-Year CAGR | -14.50% | 34.73% |
5-Year CAGR | -57.60% | 19.59% |
* Compound Annual Growth Rate
Here are more details on the SU-RAJ DIAMONDS share price and the REMUS PHARMA share price.
Moving on to shareholding structures...
The promoters of SU-RAJ DIAMONDS hold a 25.2% stake in the company. In case of REMUS PHARMA the stake stands at 70.6%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of SU-RAJ DIAMONDS and the shareholding pattern of REMUS PHARMA.
Finally, a word on dividends...
In the most recent financial year, SU-RAJ DIAMONDS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.
REMUS PHARMA paid Rs 2.0, and its dividend payout ratio stood at 2.6%.
You may visit here to review the dividend history of SU-RAJ DIAMONDS, and the dividend history of REMUS PHARMA.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.